SAS Output

23-JAN-2018 6:10

BREAST ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 Y 1 Recurrence Score testing 9400 9383 550 129 0 0 0 02/28/2011 424 208
            9383 550 129 0 0 0      
 
    2 Y 2 Chemo and Endocrine Therapy 5000 2547 192 53 1 0 0 02/28/2011    
        3 Endocrine Therapy Alone   2536 198 52 1 0 0      
            5083 390 105 2 0 0      
 
  S1207-Brst,Adj,Endocrine+/-Everolimus 1 Y 1 Blinded drug + Endocrine 1900 734 201 87 44 12 5 09/12/2013 446 233
        2 Blinded drug + Endocrine   746 216 104 45 17 3      
            1480 417 191 89 29 8      
 
  S1222-Brst,Fulv. +/- Ever. +/- Anastr. 1 T 1 Blinded treatment 840 12 0 0 0 0 0 05/15/2014 13 5
        2 Blinded treatment   12 0 0 0 0 0      
        3 Blinded treatment   13 0 0 0 0 0      
            37 0 0 0 0 0      
 
  S1416-Brst, TNBC/BRCA, Cis+/- ABT-888 1 Y 1 Blinded Drug + Cisplatin 333 104 92 48 24 8 0 09/15/2016 263 127
        2 Blinded Drug + Cisplatin   104 93 48 25 7 1      
            208 185 96 49 15 1      
 
  S1418-Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 Y 1 Tissue for PD-L1 testing 1000 141 139 92 49 15 3 01/18/2017 407 185
            141 139 92 49 15 3      
 
    2 Y 2 Observation 1000 62 62 40 23 4 1 01/18/2017    
        3 MK-3475 (Pembrolizumab)   58 58 39 18 7 1      
            120 120 79 41 11 2      
 
Yes A011106-Breast, Neoadj, ALTERNATE study 1 E Total Registrations   52 22 11 2 1 0 04/29/2014 247 117
            52 22 11 2 1 0      
 
  E1Z11-Brst,Genetic Predictors of AIMSS 1 E Total Registrations   148 10 6 4 1 0 08/13/2013 227 82
            148 10 6 4 1 0      
 
No A011202-Breast, Nodal XRT +/- ALND 0 E Total Registrations   155 58 29 13 2 0 03/20/2014 356 185
            155 58 29 13 2 0      
 
    1 E Total Registrations   61 20 10 4 0 0 03/20/2014    
            61 20 10 4 0 0      
 
  A011401-Breast, adj, Stage II/III HER2-, weight loss 1 E Total Registrations   101 90 43 23 8 2 10/05/2016 426 225
            101 90 43 23 8 2      
 
    2 E Total Registrations   86 76 40 19 4 2 10/05/2016    
            86 76 40 19 4 2      
 
  A011502-Brst, Adj, Nodal+&HER2-, Aspirin vs. Placebo 1 E Total Registrations   24 24 17 6 1 0 03/20/2017   209
            24 24 17 6 1 0      
 
  A221405-Breast, ET interruption, Pregnancy Outcomes 1 E Total Registrations   8 8 6 4 0 0 05/08/2017   56
            8 8 6 4 0 0      
 
  B51-Breast, Regional Nodal XRT 1 E Total Registrations   25 16 10 5 2 0 06/13/2014 447 229
            25 16 10 5 2 0      
 
  B55-Brst, Adj Olaparib for BRCA,TNBC 1 E Total Registrations   52 21 11 7 3 0 12/15/2014 408 180
            52 21 11 7 3 0      
 
    2 E Total Registrations   23 12 5 3 1 0 12/15/2014    
            23 12 5 3 1 0      
 
  E2112-Brst,Adv,Exemestane+/-Entinostat 1 E Total Registrations   44 18 8 4 0 0 04/01/2015 296 165
            44 18 8 4 0 0      
 
  EA1131-Brst, TNBC, Post-op Chemo vs Obs 0 E Total Registrations   15 10 4 1 0 0 11/12/2015 300 125
            15 10 4 1 0 0      
 
    1 P Total Registrations   8 7 4 1 1 0 11/12/2015    
            8 7 4 1 1 0      
 
  NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA 1 E Total Registrations   1 1 1 0 0 0 09/22/2017   5
            1 1 1 0 0 0      
 
  NRGBR003-Brst,Adj,TNBC,AC -> WP +/- Carbo 1 E Total Registrations   48 22 10 5 0 0 10/16/2015 436 211
            48 22 10 5 0 0